Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.12
Delayed Data
As of Feb 27
 +0.26 / +6.74%
Today’s Change
3.75
Today|||52-Week Range
10.06
-0.24%
Year-to-Date
Achillion (ACHN) Reports Narrower-Than-Expected Q4 Loss
Feb 27 / Zacks.com - Paid Partner Content
Biotech Movers: Cempra Flys High On Phase Three Results
Feb 24 / TheStreet.com - Paid Partner Content